Overall verdict
Neutral
6.1/10
1-year performance
-20.17%
Score breakdown
Down 20.2% over 1 year, 29% of the 52-week range.
Strongest: Shareholder return 9.7/10. Weakest: Valuation 5.2/10.
20 analysts, target +0.2% vs the price.
Siemens Healthineers AG, through its subsidiaries, develops, manufactures, and sells a range of diagnostic and therapeutic products and services to healthcare providers in Germany, the United States, rest of Europe, CIS, Africa, the Middle East, the Americas, the Asia Pacific, Japan, and China. It operates in four segments: Imaging, Diagnostics, Varian, and Advanced Therapies. The Imaging segment offers magnetic resonance imaging, computed tomography, X-ray, molecular imaging, and ultrasound systems; and software solutions to support the reading and structured reporting of diagnostic images from different modalities.
Its Diagnostics segment provides in-vitro diagnostic products and services to healthcare providers in the fields of general and specialty laboratory, and point-of-care diagnostics; and workflow solutions for laboratories and informatics products. The Varian segment offers microwave, cryoablation, and embolization technologies, as well as clinical professional services for cancer care that support oncology departments in hospitals and clinics; and customized support for cancer care operations.
Its Advanced Therapies segment provides products that are designed to support image-guided minimally invasive clinical procedures in various areas, such as cardiology, neurology, and oncology; angiography systems and mobile C-arms; and AI-powered clinical applications. It also offers essential technical customer service, such as maintenance and repair ; spare parts ; medical equipment performance management ;
training ; clinical education and e-learning ; planning and design ; financing ; asset management ; and managed departmental services for laboratories and healthcare facilities, as well as healthcare consulting, products, and services. It has strategic partnership with IFS to increase product lifecycle with industrial AI. The company was founded in 1896 and is headquartered in Forchheim, Germany. Siemens Healthineers AG is a subsidiary of Siemens Aktiengesellschaft.
Sector
Health Care
Industry
Health Care Equipment and Supplies
Primary listing
Xetr
Germany
CEO
Dr. Bernhard Montag Ph.D.
Founded
1896
Employees
74 000
Revenue / employee
324 558 EUR
Next earnings
November 5, 2026 (Q4 2026)
Research uses the underlying stock’s market history. The purchase quote is calculated separately when you review your order.
52-week high
49.71 EUR
52-week low
32.81 EUR
1-year performance
-20.17%
Declining
Year-to-date performance
-16.71%
Declining
Drawdown
-24.02%
Marked drawdown
Position in the 52-week range
29% of range
Range: 48.40 EUR - 54.40 EUR (3 methods agree)
The price implies growth of 4.15% per year; the company grows at 6.29%.
Gross margin 39.0%, net margin 9.6%, ROIC 7.4%, ROE 12.0%.
Net margin
9.55%
Fair
Sector 8.18%|S&P 12.97%
Gross margin
39.02%
Low
Return on equity (ROE)
12.03%
Exceptional
Sector 6.97%|S&P 16.52%
Return on invested capital (ROIC)
7.39%
High
Free cash flow margin (FCF)
9.56%
Fair
Profit-to-cash conversion (FCF conversion)
1.00x
High
Margin stability
1.0 pts
Very steady
Revenue to net income
Growth
6.5/10Revenue up 1.8% over 1 year, 10.1% a year over 5, EPS 6.3% a year over 5.
Revenue (trailing 12 months)
23.2Md EUR
Revenue growth (1y)
1.80%
Moderate
Revenue growth (3y)
7.65%
Moderate
EPS growth (1y)
22.00%
Hyper-growth
EPS CAGR (5y)
6.29%
Low
EPS revisions (3 months)
4.76%
Revised up
Valuation
5.2/10P/E 19.1x, forward P/E 18.6x, EV/EBITDA 11.8x, PEG 3.04. The multiple sits in the 10th percentile of its own 5-year history.
P/E (TTM)
19.1x
Fair
Sector 29.3x|S&P 23.0x
Forward P/E
18.6x
Fair
EV / EBITDA
11.8x
Fair
Sector 16.0x|S&P 14.5x
PEG
3.04
Very expensive
Sector 1.76|S&P 0.86
Fair value (reverse DCF)
51.40 EUR
Undervalued
P/E vs its own 5-year history
among the 10% lowest valuations
Far cheaper than usual
Market cap
41.5Md EUR
Financial strength
5.3/10Cash covers 15.7% of the debt, net debt/EBITDA 2.7x.
Net debt / EBITDA
2.7x
Stretched
Gearing (net debt / equity)
65.98%
Tight
Cash
2.3Md EUR
Cash / market cap
5.53%
Tight
Cash / total debt
15.73%
Tight
Net debt
12.3Md EUR
Equity
18.6Md EUR
Closed daily candles, 2 years
Last close on September 24, 2026: 37.21 EUR
- MM2038.52
- MM5038.23
- MM20038.52
- RSI 1437.4
Top panel: closed candles, 20, 50 and 200-day moving averages, with volume in grey. Bottom panel: 14-day RSI with dashed 30 and 70 levels.
200-day average slope, 1 month
-1.12%
200-day average slope, 3 months
-6.42%
50-day average slope, 1 month
+4.56%
Price structure
higher-low
Bullish RSI divergence
No
20-day volatility
0.95 % per day
Volatility change
-36.81%
Forecasts by fiscal year
| Fiscal year | EPS | Normalised EPS | Revenue | EBITDA | Net income |
|---|---|---|---|---|---|
| 2026 | 2.03 (13) | 2.34 (17) | 23 587 (18) | 4 663 (17) | 2 291 (11) |
| 2027 | 2.09 (13) | 2.35 (17) | 24 972 (18) | 4 932 (17) | 2 358 (11) |
Amounts in millions of EUR, EPS in EUR per share. In brackets, the number of analysts. Consensus as of September 23, 2026.
Same sub-industry: 190 companies behind the medians.
| # | Company | Code | Country | Overall / 10 | Fundamentals / 10 | Mkt cap | P/E | Net margin | Revenue growth | ROIC | Net debt / EBITDA | FCF yield | 1-year perf. |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | MDT | 7.0 | 7.1 | 114Md USD | 22.0x | 13.9 % | 13.7 % | 7.0 % | 2.0x | 5.4 % | -6.7 % | ||
| 2 | BSX | 6.9 | 7.1 | 64.7Md USD | 18.1x | 17.5 % | 7.5 % | 10.5 % | 1.8x | 5.6 % | -54.3 % | ||
| 3 | SYK | 6.9 | 7.5 | 105Md USD | 28.3x | 14.4 % | 9.4 % | 10.0 % | 1.7x | 4.5 % | -27.6 % | ||
| 4 | ABT | 6.6 | 6.3 | 179Md USD | 33.5x | 11.6 % | 13.0 % | 7.5 % | 0.5x | 4.4 % | -25.3 % | ||
| 5 | ISRG | 6.5 | 6.8 | 141Md USD | 45.6x | 28.4 % | 18.5 % | 17.4 % | -1.6x | 2.3 % | -11.4 % | ||
| 6 | IDXX | 6.3 | 6.4 | 41.1Md USD | 36.7x | 25.0 % | 9.7 % | 56.6 % | 0.5x | 3.0 % | -20.4 % | ||
| 7 | EW | 6.2 | 5.6 | 50.0Md USD | 51.5x | 15.0 % | 13.6 % | 8.7 % | -2.0x | 2.9 % | 15.4 % | ||
| 8 | SHL | 6.1 | 6.6 | 47.2Md USD | 19.1x | 9.6 % | 1.8 % | 7.4 % | 2.7x | 5.3 % | -20.2 % | ||
| 9 | BDX | 5.7 | 5.1 | 49.7Md USD | 55.1x | 6.2 % | 5.4 % | 3.2 % | 3.4x | 5.1 % | 22.7 % |
